 
                Chemical Structure : GAP-134 hydrochloride
CAS No.: 943133-81-1
货号: PC-42736Not For Human Use, Lab Use Only.
Danegaptide (GAP-134, ZP1609) is a potent, orally active gap-junction modifier, prevents significantly conduction velocity slowing at 10 nM compared with vehicle.
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 5 mg | ¥1380 | In stock | |
| 10 mg | ¥2180 | In stock | |
| 25 mg | ¥3780 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
	Danegaptide (GAP-134, ZP1609) is a potent, orally active gap-junction modifier, prevents significantly conduction velocity slowing at 10 nM compared with vehicle.
	Danegaptide (GAP-134, ZP1609) has highly desirable in vitro and in vivo safety profile including (1) lack of direct effects on membrane ion currents, hERG inhibition, and CYP450 liabilities, (2) negative AMES result, (3) a benign NovaScreen profile, and (4) no effects on systemic hemodynamics.
| 分子量 | 327.7634 | |
| 分子式 | C14H18ClN3O4 | |
| 外观性状 | Solid | |
| 储存条件 | 
 | 
 | 
| Solubility | 10 mM in DMSO | |
| Chemical Name/SMILES | L-Proline, glycyl-4-(benzoylamino)-, hydrochloride (1:1), (4R)- | |
1. Butera JA, et al. J Med Chem. 2009 Feb 26;52(4):908-11.
2. Rossman EI, et al. J Pharmacol Exp Ther. 2009 Jun;329(3):1127-33.
3. Hennan JK, et al. J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):207-14.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright